Elekta (OTCMKTS:EKTAY) Shares Gap Up – Time to Buy?

Shares of Elekta AB (OTCMKTS:EKTAY) gapped up prior to trading on Wednesday. The stock had previously closed at $5.09, but opened at $5.2850. Elekta shares last traded at $5.28, with a volume of 2,088 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold”.

Elekta Stock Performance

The company has a fifty day moving average of $5.33 and a two-hundred day moving average of $5.52. The firm has a market capitalization of $1.95 billion, a price-to-earnings ratio of -44.00 and a beta of 1.03. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.62 and a current ratio of 0.86.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. Elekta had a positive return on equity of 13.47% and a negative net margin of 2.38%.The business had revenue of $372.30 million during the quarter. As a group, equities research analysts predict that Elekta AB will post 0.43 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company that develops and supplies equipment, software and related services for radiation oncology and neurosurgery. Its technologies are used by hospitals and cancer treatment centers to plan and deliver precision radiation treatments for patients with cancer and neurological disorders.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, brachytherapy solutions, treatment-planning and oncology information software, and magnetic resonance-guided radiation therapy technology.